Pharmacological dependencies of pancreatic cancer
Faculty of Medicine - Technical University of Munich
I started my medical studies in 2019 at Ludwig-Maximilians-University (LMU) in Munich.
After finishing the preclinical part in 2021, I chose to continue the clinical one at TU München.
Since 2022 I am part of the Saur lab, looking for the perfect synergism among drugs for pancreatic cancer cells.
TUM Department of Chemistry
Born in Argentina, raised in the US and now studying Biochemistry at the Technical University of Munich.
I joined the Saur Lab in 2022 as a student assistant after completing my research laboratory course.
I took on this position during my studies to broaden my knowledge through practical experience and to gain first insights into my future career.
Treatment-induced adaptive immune responses in pancreatic ductal adenocarcinoma
Faculty of Medicine - RWTH Aachen University
CRISPR/Cas9 screens to uncover resistance mechanisms to PDK1-loss in pancreatic ductal adenocarcinoma
Faculty of Medicine - Ludwig-Maximilians-University (LMU) Munich
Characterization of tumor-associated macrophages in pancreatic ductal adenocarcinoma tumor progression
Faculty of Medicine - Technical University of Munich
Therapy resistance
CRISPR screening
CRISPRa screening in prancreatic ductal adenocarcinoma
I studied preclinical medicine at the Ludwig-Maximilians-University (LMU) Munich from 2015-2017 and have been continuing my clinical studies at the Technical University of Munich (TUM) since 2017. After finishing the preclinical part of my course, I started studying B.A. Philosophy at the LMU in 2017, parallel to my medical studies. In April 2020 I joined the Saur lab to work on my MD thesis in translational medicine (Dr. med. sci) on CRISPRa screening in PDAC.
Faculty of Medicine - Technical University of Munich
